Law professor comments on malpractice risk article
Gary Marchant, the ASU Lincoln Professor of Emerging Technologies, Law and Ethics, and executive director of the College of Law’s Center for Law, Science & Innovation, was quoted in a June 27 article on Genomeweb’s Pharmacogenomics Reporter page.
In “Study Finds Docs Could Face Greater Malpractice Risk in Personalized Rx Era,” by reporter Turna Ray, Marchant discussed a recent study that he and Rachel Lindor, a Center Scholar and 2011 law school graduate, conducted. They identified more than 50 cases in which patients sued their doctors or other health professionals for negligence in recommending, conducting or reporting results from genetic tests.
Their findings will be published in detail in the July issue of Personalized Medicine.
To read the full Genomeweb article, click here.
Marchant’s research interests include the use of genetic information in environmental regulation, risk and the precautionary principle, legal aspects of personalized medicine, and regulation of emerging technologies such as nanotechnology, neuroscience and biotechnology. He teaches courses in Environmental Law, Law, Science & Technology, Genetics and the Law, Biotechnology: Science, Law and Policy, and Nanotechnology Law & Policy. Marchant is a Senior Sustainability Scientist in the ASU Global Institute of Sustainability, Associate Director of the ASU Origins Initiative and a professor in ASU’s School of Life Sciences.
Janie Magruder, Jane.Magruder@asu.edu
Sandra Day O'Connor College of Law